Step Michael D

Avg. Two Year Performance

(81%) Avg. Purchase Return
(34%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(14%)(29%)(18%)13%(81%)
Purchase Success Rate2 of 40 of 42 of 42 of 40 of 4
Average Sale Return(4%)(8%)0%0%0%
Sale Success Rate0 of 40 of 40 of 40 of 40 of 4

Ritter Pharmaceuticals, Inc.

Drugs » Biotechnology

CEO, Director:

Holdings: 50.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Santarus Inc.

Drugs » Drug Manufacturers - Other

SVP, Corporate Development:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--